Meeting report from the 17th scientific meeting of the international bone and mineral societyJune 24-29, 2007 in Montreal, Quebec, Canada

[1]  T. Martin,et al.  IL-23 Inhibits Osteoclastogenesis Indirectly through Lymphocytes and Is Required for the Maintenance of Bone Mass in Mice1 , 2008, The Journal of Immunology.

[2]  N. Schalij-Delfos,et al.  Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo. , 2007, Investigative ophthalmology & visual science.

[3]  S. Vukicevic,et al.  Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. , 2007, Cancer research.

[4]  Antoinette Wetterwald,et al.  BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. , 2007, The American journal of pathology.

[5]  M. McKee,et al.  Endocrine Regulation of Energy Metabolism by the Skeleton , 2007, Cell.

[6]  G. Karsenty.  Update on the transcriptional control of osteoblast differentiation , 2007 .

[7]  M. Bianchi.  Treating osteoporosis in young patients: Looking for consensus , 2007 .

[8]  G. Karsenty.  Genetic study of children's bone health and its therapeutic application , 2007 .

[9]  K. Wenger,et al.  Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading. , 2007, Bone.

[10]  S. Cummings,et al.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. , 2007, The New England journal of medicine.

[11]  J. Cauley,et al.  Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass. , 2007, Bone.

[12]  A. Gundlach,et al.  Galanin treatment offsets the inhibition of bone formation and downregulates the increase in mouse calvarial expression of TNFalpha and GalR2 mRNA induced by chronic daily injections of an injurious vehicle. , 2007, Bone.

[13]  J. Aubin,et al.  Leukemia Inhibitory Factor Influences the Fate Choice of Mesenchymal Progenitor Cells , 2007, Stem cells.

[14]  S. Teitelbaum.  Osteoclasts: what do they do and how do they do it? , 2007, The American journal of pathology.

[15]  M. Karsdal,et al.  Active osteoclasts are required for PTH anabolic effects in young female rats , 2007 .

[16]  M. Bouxsein,et al.  Fugu parathyroid hormone 1: A potential new anabolic treatment for osteoporosis , 2007 .

[17]  D. Hume,et al.  The endosteal bone niche contains macrophages that regulate osteoblast function , 2007 .

[18]  Hwj Rik Huiskes,et al.  Osteoclast constraint in trabecular remodeling , 2007 .

[19]  Satoshi Mori,et al.  1α,25-Dihydroxy-2β(3-hydroxypropoxy)vitamin D3 (ED-71) suppressed callus remodeling but did not interfere with fracture healing in rat femora , 2007 .

[20]  W. Hsu,et al.  Craniosynostosis caused by Axin2 deficiency is mediated through distinct functions of beta-catenin in proliferation and differentiation. , 2007, Developmental biology.

[21]  B. Komm,et al.  Wnt signaling and osteoblastogenesis , 2007, Reviews in Endocrine and Metabolic Disorders.

[22]  Ming Zhao,et al.  The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells. , 2006, Cancer research.

[23]  C. Shin,et al.  CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter. , 2006, Journal of molecular endocrinology.

[24]  L. Calvi.  Hematopoietic-osteoblastic interactions in the hematopoietic stem cell niche , 2006 .

[25]  G. Strewler.  The stem cell niche and bone metastasis , 2006 .

[26]  D. Scadden,et al.  The hematopoietic stem cell in its place , 2006, Nature Immunology.

[27]  J. Hoenderop,et al.  The ß-Glucuronidase Klotho Hydrolyzes and Activates the TRPV5 Channel , 2005, Science.

[28]  J. Aubin,et al.  GP130/OSMR is the only LIF/IL‐6 family receptor complex to promote osteoblast differentiation of calvaria progenitors , 2005, Journal of cellular physiology.

[29]  D. Bauer,et al.  Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. , 2005, Endocrine reviews.

[30]  Bart O. Williams,et al.  Essential Role of β-Catenin in Postnatal Bone Acquisition* , 2005, Journal of Biological Chemistry.

[31]  P. Roughley,et al.  FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice , 2005, The Journal of cell biology.

[32]  Masaki Noda,et al.  Leptin regulation of bone resorption by the sympathetic nervous system and CART , 2005, Nature.

[33]  T. Martin,et al.  Osteoclast-derived activity in the coupling of bone formation to resorption. , 2005, Trends in molecular medicine.

[34]  M. Bouxsein,et al.  Decreased BMD and Limb Deformities in Mice Carrying Mutations in Both Lrp5 and Lrp6 , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  C. Christiansen,et al.  Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  R. Baron,et al.  Gp130-mediated signaling is necessary for normal osteoblastic function in vivo and in vitro. , 2004, Endocrinology.

[37]  B. Kemp,et al.  Identification of a Parathyroid Hormone in the Fish Fugu rubripes , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  J. Aubin.  The importance of STAT-smad cross-talk in bone , 2003 .

[39]  S. Takeda,et al.  Interleukin-11 as a Stimulatory Factor for Bone Formation Prevents Bone Loss with Advancing Age in Mice* , 2002, The Journal of Biological Chemistry.

[40]  G. Stein,et al.  CCAAT/Enhancer-binding Proteins (C/EBP) β and δ Activate Osteocalcin Gene Transcription and Synergize with Runx2 at the C/EBP Element to Regulate Bone-specific Expression* , 2002, The Journal of Biological Chemistry.

[41]  J. Aubin.  Your partner makes all the difference , 2001 .

[42]  M. Kelz,et al.  Overexpression of ΔFosB transcription factor(s) increases bone formation and inhibits adipogenesis , 2000, Nature Medicine.

[43]  K. Mann,et al.  Bone marrow accessory cells regulate human bone precursor cell development. , 2000, Experimental hematology.

[44]  J. Aubin.  Osteoprogenitor cell frequency in rat bone marrow stromal populations: Role for heterotypic cell–cell interactions in osteoblast differentiation , 1999, Journal of cellular biochemistry.

[45]  Allan Bradley,et al.  Increased bone formation in osteocalcin-deficient mice , 1996, Nature.

[46]  S. Boonen,et al.  Androgens and bone. , 2004, Calcified tissue international.

[47]  I. Reid,et al.  The effect of leukemia inhibitory factor on bone in vivo. , 1993, Endocrinology.

[48]  D. Gearing,et al.  Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.